EG210853 Inhibitors
EG210853 inhibitors are a class of chemical compounds specifically designed to target and regulate the activity of a protein or molecule designated as EG210853. While the precise biological function of EG210853 may not be fully characterized, it is likely a key player in a specific cellular pathway, possibly involved in processes such as enzyme catalysis, signal transduction, or cellular regulation. The protein could be part of a complex network of interactions, influencing various cellular activities, including metabolic processes, gene expression, or cellular communication. Inhibitors of EG210853 are developed to bind to this protein, thereby interfering with its normal function, which allows researchers to explore the protein's role in maintaining cellular homeostasis and its broader impact on cellular physiology.
The mechanism of action for EG210853 inhibitors generally involves binding to specific regions on the EG210853 molecule. These inhibitors might target the active site of EG210853 if it acts as an enzyme, preventing it from interacting with its natural substrates and thereby halting its catalytic activity. Alternatively, they could bind to allosteric sites, inducing conformational changes that reduce the protein's activity or disrupt its interactions with other molecules or proteins within the cell. This disruption can lead to a cascade of effects within the cellular pathway that EG210853 is a part of, providing valuable insights into the protein's function and the broader network of interactions it participates in. By studying the effects of inhibiting EG210853, researchers can gain a deeper understanding of the molecular mechanisms that govern various cellular processes and how disruptions in these processes can impact overall cell function and behavior. This knowledge is crucial for mapping out the intricate biochemical pathways that sustain cellular life and for identifying the specific contributions of EG210853 to these pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Direct inhibitor disrupting RNA polymerase II activity, preventing transcription initiation. By inhibiting the key enzyme involved in transcription, this compound directly impacts Zfp947's predicted function as a DNA-binding transcription factor. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Direct inhibitor binding to RNA polymerase II, blocking transcription elongation. By hindering RNA polymerase II, this compound directly influences Zfp947's function, as it relies on the polymerase for its predicted activities in DNA binding and transcription regulation. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Direct inhibitor targeting CDK9, a regulator of RNA polymerase II. By inhibiting CDK9, this compound directly affects transcriptional elongation, impacting Zfp947's role in RNA polymerase II-specific DNA binding activity and transcription regulation. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Direct inhibitor targeting XPB, a subunit of the transcription factor TFIIH. By inhibiting XPB, this compound directly affects the initiation of transcription, influencing Zfp947's function in RNA polymerase II cis-regulatory region sequence-specific DNA binding. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
CDK inhibitor indirectly influencing Zfp947. By inhibiting CDKs, this compound alters the cell cycle, impacting the availability of RNA polymerase II and influencing Zfp947's function in the regulation of transcription by RNA polymerase II and DNA binding. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Indirect inhibitor affecting Zfp947 through DNA topoisomerase I inhibition. By trapping the enzyme on DNA, this compound indirectly influences RNA polymerase II function, affecting Zfp947's role in DNA binding and transcriptional regulation. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Antimetabolite indirectly impacting Zfp947. By interfering with nucleotide synthesis, this compound indirectly affects RNA polymerase II-dependent transcriptional regulation, influencing Zfp947's function in the regulation of transcription by RNA polymerase II. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor indirectly influencing Zfp947 through chromatin remodeling. By altering histone acetylation, this compound indirectly impacts RNA polymerase II-dependent transcription, affecting Zfp947's role in the regulation of transcription by RNA polymerase II. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Indirect inhibitor influencing Zfp947 through DNA crosslinking. By forming covalent adducts with DNA, this compound indirectly affects RNA polymerase II function, impacting Zfp947's role in DNA binding and the regulation of transcription by RNA polymerase II. | ||||||